|
RESERVED AREA
| LANGUAGE
Lung Cancer Study Group
GECP
WHO WE ARE
STATUTS
SOCIAL BODIES
SCIENTIFIC COMMISSION
ACTION PLAN
CONTACTS
ASSOCIATED CENTERS
NEW PARTNERS
CLINICAL TRIALS
WHAT IS A CLINICAL TRIAL?
GEP´s CLINICAL TRIALS
ESTUDOS OBSERVACIONAIS EM RECRUTAMENTO NACIONAL
Em atualização
Em atualização
use
ONGOING TRIALS
ENSAIOS RECRUTAMENTO NACIONAL INVESTIGADOR
PUBLICATIONS
GECP JOURNAL
JOURNAL ACCESS
Critérios de publicação
campaign
interviews
books
EVENTS
GECP
Spring Meeting: Open Registration
PREVIOUS CONGRESSES
MEETINGS
SPRING
AUTUMN
SCIENTIFIC SPONSORSHIP
patrocinado
GRANTS AND AWARDS
GECP GRANT
GECP AWARD
PATIENTS AND CAREGIVERS
LUNG CANCER
CANCER AND COVID-19
PUBLICATIONS
FREQUENTLY ASKED QUESTIONS
TOBACCO
ASSOCIATIONS
PATIENT'S DUTIES AND RIGHTS
LEGISLATION
Ensaios Clínicos em recrutamento nacional
Por iniciativa do investigador
Characterization of targeted therapy resistance mechanisms in EGFR/ALK/ROS1/BRAF-positive NSCLC by gene panel NGS in circulating cell-free DNA
NGS-BL-CaPu
IPO Porto
Manuel R. Teixeira
links:
Study Protocol
Aprovação
Consentimento Informado
Informação Participante
©2022 Copyright GECP
GECP
WHO WE ARE
STATUTS
SOCIAL BODIES
SCIENTIFIC COMMISSION
ACTION PLAN
CONTACTS
ASSOCIATED CENTERS
NEW PARTNERS
CLINICAL TRIALS
WHAT IS A CLINICAL TRIAL?
GEP´s CLINICAL TRIALS
ESTUDOS OBSERVACIONAIS EM RECRUTAMENTO NACIONAL
Em atualização
Em atualização
use
ONGOING TRIALS
ENSAIOS RECRUTAMENTO NACIONAL INVESTIGADOR
PUBLICATIONS
GECP JOURNAL
JOURNAL ACCESS
Critérios de publicação
campaign
interviews
books
EVENTS
GECP
Spring Meeting: Open Registration
PREVIOUS CONGRESSES
MEETINGS
SCIENTIFIC SPONSORSHIP
patrocinado
GRANTS AND AWARDS
GECP GRANT
GECP AWARD
PATIENTS AND CAREGIVERS
LUNG CANCER
CANCER AND COVID-19
PUBLICATIONS
FREQUENTLY ASKED QUESTIONS
TOBACCO
ASSOCIATIONS
PATIENT'S DUTIES AND RIGHTS
LEGISLATION
